Edaravone for acute stroke: Meta-analyses of data from randomized controlled trials

References

• Wang YJ, Zhang SM, Zhang L, Wang CX, Dong Q, Gao S, Huang RX, Huang YN, Lv CZ, Liu M, et al. Chinese guidelines for the secondary prevention of ischemic stroke and transient ischemic attack 2010. Central Nervous System Neuroscience & Therapeutics 2012;18(2):93–101
   PubMed Web of Science ®Google Scholar
• Yu JG, Zhou RR, Cai GJ. From hypertension to stroke: Mechanisms and potential prevention strategies. Central Nervous System Neuroscience & Therapeutics 2011;17(5):577–584
   PubMed Web of Science ®Google Scholar
• Shinohara Y, Saito I, Kobayashi S, Uchiyama S. Edaravone (radical scavenger) versus sodium ozagrel (antiplatelet agent) in acute noncardioembolic ischemic stroke (EDO trial). Cerebrovascular Diseases 2009;27(5):485–492
   PubMed Web of Science ®Google Scholar
• Zhang XH, Lei H, Liu AJ, Zou YX, Shen FM, Su DF. Increased oxidative stress is responsible for severer cerebral infarction in stroke-prone spontaneously hypertensive rats. Central Nervous System Neuroscience & Therapeutics 2011;17(6):590–598
   PubMed Web of Science ®Google Scholar
• Otomo E, Edaravone Acute Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovascular Diseases 2003;15(3):222–229
   PubMed Web of Science ®Google Scholar
• Dalal PM. Ischaemic strokes: Management in first six hours. Neurology India 2001;49(2):104–115
   PubMed Web of Science ®Google Scholar
• Yoshida H, Yanai H, Namiki Y, Fukatsu-Sasaki K, Furutani N, Tada N. Neuroprotective effects of edaravone: A novel free radical scavenger in cerebrovascular injury. Central Nervous System Drug Reviews 2006;12(1):9–20
   Google Scholar
• Feng S, Yang Q, Liu M, Li W, Yuan W, Zhang S, Wu B, Li J. Edaravone for acute ischaemic stroke. Cochrane Database of Systematic Reviews 2011;Dec 7(12):CD007230
   Google Scholar
• Yang J, Liu M, Zhou J, Zhang S, Lin S, Zhao H. Edaravone for acute intracerebral haemorrhage. Cochrane Database of Systematic Reviews 2011;Feb 16(2):CD007755
   Google Scholar
• Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated march 2011]; Available from: www.cochrane-handbook.org
   Google Scholar
• Review Manager (RevMan). Cochrane handbook for systematic reviews of interventions [Computer program]. Version 5.1. [updated March 2011]. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2011
   Google Scholar
• Bu SF, Yin SL. Clinical analysis of edaravone combined with low molecular weight heparin sodium in treatment of progressive stroke. Chinese Journal of Practical Nervous Diseases 2008;11:122–123
   Google Scholar
• Li C, Zhou H, Xu C, Xu Y. The role of edaravone in treatment of acute cerebral infarction. Practical Journal of Medicine and Pharmacy 2008;25:1313–1314
   Google Scholar
• Gu XL, Gu X, Ding X, Di Q, Zhao Z, Chen J, Li J. Edaravone in treatment of massive cerebral infarction. Chinese Journal of New Drugs and Clinical Remedies 2005;24:113–116
   Google Scholar
• Huang J, Chen Z, Zhu X. Clinical efficacy of edaravone on acute cerebral infarction. Chinese Journal of Practical Nervous Diseases 2006;9:23–24
   Google Scholar
• Li XF. Clinical analysis on treatment of acute cerebral infarction with edaravone. Journal of Clinical & Experimental Medicine 2009;8:24–25
   Google Scholar
• Liu J, Jia L, Shang H, Zhang H. Observation of curative effect of edaravone in treatment of acute cerebral infarction complicated with hypertension. Chinese Journal of Practical Nervous Diseases 2010;13:55–56
   Google Scholar
• Luo Z, Yuan G, Fu L. Clinical observation of edaravone in treatment of acute cerebral infarction. Modern Practical Medicine 2006;18:477
   Google Scholar
• Yan R, Li Z, Yang X. Efficacy of edaravone injection in treatment of acute ischemic stroke. Chinese Journal of Clinical Pharmacology and Therapeutics 2011;16:190–195
   Google Scholar
• Zhang M, Xu LJ, Deng LY. Efficacy and safety evaluation of edaravone injection in treatment of acute cerebral infarction: A multicenter, double blind and randomized controlled clinical trial. Chinese Journal of New Drugs and Clinical Remedies 2007;26:105--108
   Google Scholar
• Zhang XY, Wang L, Fan D. The application of rt-PA combined with edaravone in treatment of hyperacute cerebral infarction. Chinese Journal of Neurology 2008;41:201–203
   Google Scholar
• Zhao J, Huang X, Zhou S, Fan L, Wu Y, Cheng X. Clinical observation of edaravone combined with local sub-hypothermia therapy in treatment of acute cerebral infarction. Clinical Education of General Practise 2007;5:400–403
   Google Scholar
• Zheng Z, Huang M, Liu H. Effect of edaravone combined with Plantula Ixeridis Sonchifoliae on relieving neurologic impairment symptoms of patients with acute cerebral infarction. Journal of Guangzhou University of Traditional Chinese Medicine 2010;27:214–217
   Google Scholar
• Zhong JL. Observation of curative effect of edaravone in treatment of acute cerebral infarction. Practical Clinical Medicine 2010;11:27–28
   Google Scholar
• Zhu MC, Huang J. Clinical observation of edaravone in treatment of acute cerebral infarction complicated with diabetes mellitus. Prevention and Treatment of Cardiovascular and Cerebrovascular Disease 2008;8:324–326
   Google Scholar
• Zou QH, Luo W, Luo Q. Clinical observation of batroxobin (DF-521) combined with edaravone in treatment of progressive cerebral infaction. Chinese Journal of Primary Medicine and Pharmacy 2008;15:994–995
   Google Scholar
• Geng Z, Sun X, Shen J. Clinical efficacy of edaravone on acute cerebral hemorrhage. Shanghai Medical Journal 2004;22:917–919
   Google Scholar
• Li D, Shan S. Clinical efficacy of edaravone on the treatment of acute cerebral hemorrhage. Ningxia Medical Journal 2005;27:616–617
   Google Scholar
• Pang H, Li X. Effect of edaravone on neurological rehabilitation after hypertensive intracerebral hemorrhage. Anhui Medical and Pharmaceutical Journal 2007;11:1073–1074
   Google Scholar
• Wang GD, Shen X, Xu ZX. Chinical efficacy of edaravone on acute cerebral hemorrhage. Hainan Medical Journal 2007;18:3–4
   Google Scholar
• Chen YG. Effect of edaravone in treatment of hypertensive cerebral hemorrhage. Hainan Medical Journal 2008;28:77–78
   Google Scholar
• Sang D, Wei D, Yin L. Edaravone for treatment of cerebral hemorrhage:report of 30 cases. Journal of Bengbu Medical College 2008;33:533–534
   Google Scholar
• Shi J, Li Q, Li G. Clinical efficacy of edravone on the treatment of acute cerebral hemorrhage. Pharmaceutical and Clinical Research 2008;16:134–136
   Google Scholar
• Hao W. Edaravone for acute cerebral hemorrhage. Proceeding of Clinical Medicine 2009;18:626–627
   Google Scholar
• He J, Li H, Zhang H. Clinical efficacy of edaravone for acute cerebral hemorrhage in the stroke unit. Journal of Qiqihar Medical College 2009;30:2887–2888
   Google Scholar
• Zhao R, Wang C, Hu C. Influence and observation of curative effect of edaravone in neuron specific enolase and s-100βprotein of acute cerebral hemorrhage. Clinical Focus 2009;24:1085–1087
   Google Scholar
• Ma Q, Qiao Y. Effect of edaravone in the treatment of acute cerebral hemorrhage. Journal of Shanxi Medical University 2010;41:642–643
   Google Scholar
• Sang J, Gong Q. Clinical observation of edaravone for acute cerebral hemorrhage. Clinical Focus 2010;25:2146–2148
   Google Scholar
• Wang X, Zuo X, Wang W. Clinical observation of edaravone for hypertensive cerebral hemorrhage. Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care 2010;17:182
   Google Scholar
• Wang Z, Zhao L, Yang Y. Neural functional recovery of edaravone for postoperative cerebral hemorrhage. Chinese Journal of Modern Drug Application 2010;4:126–128
   Google Scholar
• WHO collaborating centre international drug monitoring. WHO pharmaceuticals newsletter; 2002
   Google Scholar
• Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of the American Medical Association 1995;273(5):408–412
   PubMed Web of Science ®Google Scholar